Researchers Develop Promising Hantavirus Treatments Amid Limited Funding
Researchers in Chile, Argentina, and the United States are working on developing treatments and vaccines for hantavirus, a rare but deadly rodent-borne virus. Despite the virus being known for decades, there has been limited investment in its research due to its rarity and difficulty in spreading between humans. Recent developments include a drug used for autoimmune diseases showing promise in treating hantavirus symptoms. The virus gained attention after an outbreak on a cruise ship, highlighting the need for continued research. The Andes virus, a type of hantavirus, is of particular interest as it can spread between people. Efforts are underway to develop vaccines and treatments, but funding remains a challenge. 
